Addressing Climate Change by Changing Our Food Systems
WASHINGTON, D.C. / ACCESSWIRE / January 14, 2025 / The year 2024 was the hottest year on record. For the first time the average global temperature rose to 1.6C above preindustrial levels, exceeding the 1.5C vital to preventing accelerating climate change. The effects of climate change are now visible on every continent.Image: www.freepik.com
Up to a third of global greenhouse gas production to date can be attributed to animal agriculture and food systems. Yet, most climate change solutions neglect the importance of food systems in climate change mitigation. In the article, ‘Solving Climate Change Requires Changing Our Food Systems,' published in leading scientific journal Oxford Open Climate Change, prominent scientists from around the world propose that the pressing nature of irreversible climate change requires rethinking our food systems.
Lead researcher Dr Feigin and her co-authors assert that "we must undertake a global shift to a fundamentally plant-based diet and a gradual global reduction and eventual phaseout of intensive factory farming, the most prolific and damaging form of agriculture."
Our growing demand for meat and animal products is unsustainable. The FAO estimates that demand for meat will double by 2050, which would require that approximately 80% of existing forests and shrubland would have to be converted into land devoted to raising animals. Such a trajectory would have devastating consequences for us and the planet.
"As the world population increases, food insecurity and starvation will intensify if we continue to rely on a model of food production (i.e. animal factory farming) which is extraordinarily inefficient and resource intensive", the study authors contend. The authors present strategies to achieve a re-thinking of current food systems including the removal of government subsidies and higher taxation of animal products to account for externalized costs of animal agriculture.
The health benefits and savings to healthcare costs of adopting a fundamentally plant-based diet are profound. Consumption of animal products contributes to the development of many chronic diseases. Moreover, "antibiotic-resistant infections in humans are associated with proximity to animal farms and are a global health threat, killing approximately 700,000 people worldwide annually," the authors declare. The proliferation of industrialized animal farming has brought us closer than ever before to the outbreaks of lethal human zoonoses such as avian influenza (bird flu) and H1N1 (swine flu) resulting from factory farming operations.
The authors suggest that plant-based diets pet foods should also be included in the global shift away from animal agriculture. Pet dogs and cats consume at least 9% of all livestock annually and nutritionally sound plant-based pet diets would free up large amounts of land which could be used for climate mitigation.
Critical changes to our food system and consumption habits will require a shift in global mindset - lead author Dr Feigin states, "the future of humanity and all life on our planet depends on sustainability, and the data indicate that we will not succeed on the issue of climate change unless we change the way that we produce and consume food."
Contact Information
Svetlana Feigin
Dr
sfeigin@alllifeinstitute.org
SOURCE: All Life Institute
View the original press release on accesswire.com
All Life Institute

Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
Datavault AI Announces Target to Expand its AI Driven Data Monetization Network to Over 100 Cities Across the Contiguous United States, Starting in the Second Half of 2026 with Corresponding 2027 Revenue Target12.1.2026 14:05:00 CET | Press release
Datavault AI expects to have a fully operational network with over 100 nodes across 33 cities nationwide, generating revenue in the second half of 2026. Target revenue for this project is $400 to $500 million, thereby supporting the $200 million revenue guidance for 2026. With the full deployment of Datavault AI's nodes across 100+ cities throughout the United States, the 2027 revenue target is $2.0 to $3.0 billion for 2027. New York and Philadelphia edge network activation positions Datavault AI to potentially capture a significant share of the insurance and financial sectors, the healthcare industry, and enterprise opportunities. PHILADELPHIA, PENNSYLVANIA / ACCESS Newswire / January 12, 2026 / Datavault AI Inc. (Nasdaq:DVLT), a leader in AI-driven data valuation, monetization, credentialing, and digital engagement technologies, today highlighted the strategic importance of its New York and Philadelphia edge network deployment with Available Infrastructure's SanQtum AI platform. This
OBI Pharma and TegMine Therapeutics Sign Exclusive Global License Agreement for Glycan-Targeting ADC12.1.2026 13:00:00 CET | Press release
Successful Delivery of Commissioned ADC Candidate to Advance the Collaboration Between OBI and TegMine TAIPEI, TW / ACCESS Newswire / January 12, 2026 / OBI Pharma (4174.TWO) announced that it has entered into a commercial license agreement with TegMine Therapeutics, Inc. (TegMine), a San Francisco-based biopharma focused on developing antibodies targeting cancer-associated glycans and glycoproteins, for a glycan-targeting ADC. Under the terms of the agreement, OBI is eligible to receive an upfront payment as well as development and commercial milestones. Following product launch, OBI will also receive royalties based on a tiered percentage of annual net sales. While the detailed financial terms are not disclosed in accordance with the confidentiality provisions, the overall deal economics are broadly comparable to those of recent similar licensing transactions in the market. TegMine will obtain the exclusive global rights to develop and commercialize the ADC under the license agreemen
Charlie's Holdings (OTCQB:CHUC) Signs Agreement with IKE Tech to Commercialize Transformational Age-Gated Vapes that Will Address FDA Concerns Related to Youth Access12.1.2026 12:00:00 CET | Press release
SBX Product Line Will Feature First-Ever AI-Powered Blockchain-Based Age-Gating System for Vape Products IKE's patented biometric BLE Bluetooth chip and blockchain-based app will enable Charlie's to ensure that underage individuals will not be able to activate or utilize the Company's age-gated products. The IKE Licensing Agreement provides CHUC with a first mover advantage in youth access prevention (one of the FDA's top priorities) and a three-year exclusivity period for age-gated nicotine analogue products. Charlie's will test market the IKE age-gating system this spring with the Company's popular SBX nicotine analogue product line; simultaneously, Charlie's intends to incorporate the revolutionary technology into its PACHA branded Electronic Nicotine Delivery Systems (ENDS). COSTA MESA, CA / ACCESS Newswire / January 12, 2026 / Charlie's Holdings, Inc. (OTCQB:CHUC) ("Charlie's" or the "Company"), an industry leader in the premium vapor products space, today reported that the Compan
Datavault AI Celebrates Successful Completion of Dream Bowl XIV, Pioneering Blockchain Innovation in Sports Entertainment12.1.2026 12:00:00 CET | Press release
On January 10, 2026, a few dozen of NFL Alumni Greats (click here for a list of participating athletes) live-autographed 100 Footballs (click here to view the autographed NFL Alumni Footballs) and 500 Jerseys (click here to view the autographed NFL Alumni Jerseys); Starting on February 1, 2026, these special, one-time, live-autographed memorabilia items are to be given away by lottery to eligible holders of Dream Bowl Meme Coin I tokens and, following their distribution date (currently set for February 21, 2026), Dream Bowl Meme Coin II tokens and will be tradable on the upcoming International NIL Exchange; $25,000 E-Sports Scholarships Raised by Sponsors were Given to Dream Bowl Madden and Team E-Sports Champions; and 70 Student Star Athletes Showcased their Talent to USFL, NFL and European League Scouts (click here to view the Special Dream Bowl XIV Participants' Jerseys). PHILADELPHIA, PENNSYLVANIA / ACCESS Newswire / January 12, 2026 / Datavault AI Inc. (NASDAQ:DVLT) ("Datavault AI
PromiCell, Inc. presents during JP Morgan's 2026 Healthcare Conference9.1.2026 18:35:00 CET | Press release
MIAMI, FL / ACCESS Newswire / January 9, 2026 / PromiCell, Inc. (the "Company"), a clinical-stage cellular immunotherapy company uniquely positioned to advance potentially curative cell therapies for cancer patients, today announced that the Company's Chief Medical Officer, John Lee, MD, Ph.D., will present interim results of the Company's lead asset PRO CAR - 201A, a STEAP1 directed CAR T cell that is currently in the clinic as a first-in-human phase 1 trial for the treatment of metastatic castration-resistant prostate cancer (mCRPC), at Biotech Showcase 2026 in San Francisco, California on Monday, January 12, 2025 at 11:15 am PST at the Franciscan D (Ballroom Level). About PromiCell, Inc. PromiCell, is a clinical-stage cellular immunotherapy company with product candidates representing highly differentiated and novel CAR T and TCR T platforms to be developed across separate solid and hematologic types of cancer. Our pipeline of innovative products includes STEAP 1 CAR T cells, HA-1 T
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom